.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
QuintilesIMS
Medtronic
Chinese Patent Office
Covington
UBS
Baxter
Queensland Health
Farmers Insurance
Julphar

Generated: September 25, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019921

« Back to Dashboard
NDA 019921 describes OCUFLOX, which is a drug marketed by Allergan and is included in one NDA. It is available from one supplier. Additional details are available on the OCUFLOX profile page.

The generic ingredient in OCUFLOX is ofloxacin. There are seventy drug master file entries for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the ofloxacin profile page.

Summary for NDA: 019921

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details

Pharmacology for NDA: 019921

Ingredient-typeQuinolones

Suppliers and Packaging for NDA: 019921

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
OCUFLOX
ofloxacin
SOLUTION/DROPS;OPHTHALMIC 019921 NDA Allergan, Inc. 11980-779 11980-779-05 1 BOTTLE, DROPPER in 1 CARTON (11980-779-05) > 5 mL in 1 BOTTLE, DROPPER

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION/DROPS;OPHTHALMICStrength0.3%
Approval Date:Jul 30, 1993TE:ATRLD:Yes

Expired Orange Book Patents for NDA: 019921

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Allergan
OCUFLOX
ofloxacin
SOLUTION/DROPS;OPHTHALMIC019921-001Jul 30, 1993► Subscribe► Subscribe
Allergan
OCUFLOX
ofloxacin
SOLUTION/DROPS;OPHTHALMIC019921-001Jul 30, 1993► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Merck
Fuji
Teva
QuintilesIMS
Cerilliant
Moodys
Deloitte
Novartis
Harvard Business School
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot